Drag a card by its title · ⚙ to size, swap or remove

The company

GeneDx Holdings Corp.

WGS · Nasdaq

Health CareProviders & FacilitiesAbove a falling averageAI

WGS stood above a rising 150-day average in 11 of the last 52 weekly readings, and has been out of that trend for the last 41 weeks. It is 2.0% above that average now. Providers & Facilities: 47% of its 53 stocks in an uptrend (−2 points in four weeks); Health Care: 28% (−9 points in four weeks).

SEC filings

Statistics

Rotation: Above a falling average
Weeks in an uptrend: out for 41
Industry in uptrend: 47% -2 in 4 wk
Insider buys, 12 months: $213.2M
Insider sales, 12 months: $34.2M
Officials’ trades on record: 0
Institutions holding: 214 (-9)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 11 of 52 weeks.

21 Apr – 20 Oct

Providers & Facilities: About half its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months18

Sale orders, 12 months33

Buyers · sellers4 · 4

Who	Did	Shares	Traded
Katherine StuelandCHIEF EXECUTIVE OFFICER	sold	1,648at $94.26	16 Sep 2026filed 18 Sep 2026
Katherine StuelandCHIEF EXECUTIVE OFFICER	sold	148at $95.41	16 Sep 2026filed 18 Sep 2026
Katherine StuelandCHIEF EXECUTIVE OFFICER	sold	1,525at $96.90	16 Sep 2026filed 18 Sep 2026
Katherine StuelandCHIEF EXECUTIVE OFFICER	sold	4,141at $98.27	16 Sep 2026filed 18 Sep 2026
Katherine StuelandCHIEF EXECUTIVE OFFICER	sold	3,039at $99.00	16 Sep 2026filed 18 Sep 2026
Kevin FeeleyCHIEF FINANCIAL OFFICER	sold	586at $94.26	16 Sep 2026filed 18 Sep 2026
Kevin FeeleyCHIEF FINANCIAL OFFICER	sold	52at $95.41	16 Sep 2026filed 18 Sep 2026
Kevin FeeleyCHIEF FINANCIAL OFFICER	sold	541at $96.90	16 Sep 2026filed 18 Sep 2026
Kevin FeeleyCHIEF FINANCIAL OFFICER	sold	1,470at $98.27	16 Sep 2026filed 18 Sep 2026
Kevin FeeleyCHIEF FINANCIAL OFFICER	sold	1,079at $99.00	16 Sep 2026filed 18 Sep 2026
Katherine StuelandCHIEF EXECUTIVE OFFICER	sold	3,692at $84.22	9 Sep 2026filed 11 Sep 2026
Kevin FeeleyCHIEF FINANCIAL OFFICER	sold	1,285at $84.22	9 Sep 2026filed 11 Sep 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders214-9 on the quarter

New · exited56 · 64

Reported value$2.2B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Corvex Management LPadded · filed 14 Aug 2026	4,784,570$328.5M	+1,556,421+48.2%
Casdin Capital, LLCadded · filed 14 Aug 2026	3,707,164$254.5M	+700,000+23.3%
BlackRock, Inc.added · filed 7 Aug 2026	1,706,239$117.1M	+155,531+10.0%
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026	1,669,441$114.6M	+334,461+25.1%
ARK Investment Management LLCadded · filed 14 Aug 2026	1,610,189$110.5M	+285,606+21.6%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLCadded · filed 12 Aug 2026	1,400,653$96.2M	+625,384+80.7%
MORGAN STANLEYadded · filed 13 Aug 2026	988,297$67.8M	+456,062+85.7%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	879,003$60.3M	+20,420+2.4%
CITADEL ADVISORS LLCadded · filed 14 Aug 2026	865,462$59.4M	+218,061+33.7%
First Light Asset Management, LLCadded · filed 14 Aug 2026	783,923$53.8M	+540,996+222.7%